Literature DB >> 31375574

Primary HIV-1 Strains Use Nef To Downmodulate HLA-E Surface Expression.

Thomas van Stigt Thans1, Janet I Akko1,2, Annika Niehrs1,2, Wilfredo F Garcia-Beltran3, Laura Richert1,4, Christina M Stürzel5, Christopher T Ford1, Hui Li6, Christina Ochsenbauer7, John C Kappes7, Beatrice H Hahn6, Frank Kirchhoff5, Glòria Martrus1, Daniel Sauter5, Marcus Altfeld1,2,8, Angelique Hölzemer9,2,10.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) has evolved elaborate ways to evade immune cell recognition, including downregulation of classical HLA class I (HLA-I) from the surfaces of infected cells. Recent evidence identified HLA-E, a nonclassical HLA-I, as an important part of the antiviral immune response to HIV-1. Changes in HLA-E surface levels and peptide presentation can prompt both CD8+ T-cell and natural killer (NK) cell responses to viral infections. Previous studies reported unchanged or increased HLA-E levels on HIV-1-infected cells. Here, we examined HLA-E surface levels following infection of CD4+ T cells with primary HIV-1 strains and observed that a subset downregulated HLA-E. Two primary strains of HIV-1 that induced the strongest reduction in surface HLA-E expression were chosen for further testing. Expression of single Nef or Vpu proteins in a T-cell line, as well as tail swap experiments exchanging the cytoplasmic tail of HLA-A2 with that of HLA-E, demonstrated that Nef modulated HLA-E surface levels and targeted the cytoplasmic tail of HLA-E. Furthermore, infection of primary CD4+ T cells with HIV-1 mutants showed that a lack of functional Nef (and Vpu to some extent) impaired HLA-E downmodulation. Taken together, the results of this study demonstrate for the first time that HIV-1 can downregulate HLA-E surface levels on infected primary CD4+ T cells, potentially rendering them less vulnerable to CD8+ T-cell recognition but at increased risk of NKG2A+ NK cell killing.IMPORTANCE For almost two decades, it was thought that HIV-1 selectively downregulated the highly expressed HLA-I molecules HLA-A and HLA-B from the cell surface in order to evade cytotoxic-T-cell recognition, while leaving HLA-C and HLA-E molecules unaltered. It was stipulated that HIV-1 infection thereby maintained inhibition of NK cells via inhibitory receptors that bind HLA-C and HLA-E. This concept was recently revised when a study showed that primary HIV-1 strains reduce HLA-C surface levels, whereas the cell line-adapted HIV-1 strain NL4-3 lacks this ability. Here, we demonstrate that infection with distinct primary HIV-1 strains results in significant downregulation of surface HLA-E levels. Given the increasing evidence for HLA-E as an important modulator of CD8+ T-cell and NKG2A+ NK cell functions, this finding has substantial implications for future immunomodulatory approaches aimed at harnessing cytotoxic cellular immunity against HIV.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  HIV-1; HLA-E; Nef

Mesh:

Substances:

Year:  2019        PMID: 31375574      PMCID: PMC6798123          DOI: 10.1128/JVI.00719-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  98 in total

1.  Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments.

Authors:  Markus Moll; Sofia K Andersson; Anna Smed-Sörensen; Johan K Sandberg
Journal:  Blood       Date:  2010-06-08       Impact factor: 22.113

2.  HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences.

Authors:  N Lee; D R Goodlett; A Ishitani; H Marquardt; D E Geraghty
Journal:  J Immunol       Date:  1998-05-15       Impact factor: 5.422

3.  Modulation of different human immunodeficiency virus type 1 Nef functions during progression to AIDS.

Authors:  S Carl; T C Greenough; M Krumbiegel; M Greenberg; J Skowronski; J L Sullivan; F Kirchhoff
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  The tyrosine binding pocket in the adaptor protein 1 (AP-1) mu1 subunit is necessary for Nef to recruit AP-1 to the major histocompatibility complex class I cytoplasmic tail.

Authors:  Elizabeth R Wonderlich; Maya Williams; Kathleen L Collins
Journal:  J Biol Chem       Date:  2007-12-11       Impact factor: 5.157

5.  Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells.

Authors:  Y Shimizu; D E Geraghty; B H Koller; H T Orr; R DeMars
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

6.  Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein.

Authors:  O Schwartz; V Maréchal; S Le Gall; F Lemonnier; J M Heard
Journal:  Nat Med       Date:  1996-03       Impact factor: 53.440

7.  Structural basis of evasion of cellular adaptive immunity by HIV-1 Nef.

Authors:  Xiaofei Jia; Rajendra Singh; Stefanie Homann; Haitao Yang; John Guatelli; Yong Xiong
Journal:  Nat Struct Mol Biol       Date:  2012-06-17       Impact factor: 15.369

Review 8.  The immune response during acute HIV-1 infection: clues for vaccine development.

Authors:  Andrew J McMichael; Persephone Borrow; Georgia D Tomaras; Nilu Goonetilleke; Barton F Haynes
Journal:  Nat Rev Immunol       Date:  2009-12-11       Impact factor: 53.106

9.  Relative resistance of HIV-1 founder viruses to control by interferon-alpha.

Authors:  Angharad E Fenton-May; Oliver Dibben; Tanja Emmerich; Haitao Ding; Katja Pfafferott; Marlen M Aasa-Chapman; Pierre Pellegrino; Ian Williams; Myron S Cohen; Feng Gao; George M Shaw; Beatrice H Hahn; Christina Ochsenbauer; John C Kappes; Persephone Borrow
Journal:  Retrovirology       Date:  2013-12-03       Impact factor: 4.602

10.  Primate lentiviruses use at least three alternative strategies to suppress NF-κB-mediated immune activation.

Authors:  Dominik Hotter; Teresa Krabbe; Elisabeth Reith; Ali Gawanbacht; Nadia Rahm; Ahidjo Ayouba; Benoît Van Driessche; Carine Van Lint; Martine Peeters; Frank Kirchhoff; Daniel Sauter
Journal:  PLoS Pathog       Date:  2017-08-31       Impact factor: 6.823

View more
  9 in total

Review 1.  Engaging innate immunity in HIV-1 cure strategies.

Authors:  Nathan L Board; Milica Moskovljevic; Fengting Wu; Robert F Siliciano; Janet D Siliciano
Journal:  Nat Rev Immunol       Date:  2021-11-25       Impact factor: 108.555

Review 2.  Antigen presentation by MHC-E: a putative target for vaccination?

Authors:  Linda Voogd; Paula Ruibal; Tom H M Ottenhoff; Simone A Joosten
Journal:  Trends Immunol       Date:  2022-03-31       Impact factor: 19.709

Review 3.  NK Cells, Monocytes and Macrophages in HIV-1 Control: Impact of Innate Immune Responses.

Authors:  Leonore Mensching; Angelique Hoelzemer
Journal:  Front Immunol       Date:  2022-05-27       Impact factor: 8.786

4.  HIV-1 Nef-mediated downregulation of CD155 results in viral restriction by KIR2DL5+ NK cells.

Authors:  Pia Fittje; Angelique Hœlzemer; Wilfredo F Garcia-Beltran; Sarah Vollmers; Annika Niehrs; Kerri Hagemann; Glòria Martrus; Christian Körner; Frank Kirchhoff; Daniel Sauter; Marcus Altfeld
Journal:  PLoS Pathog       Date:  2022-06-24       Impact factor: 7.464

5.  HIV-infected macrophages resist efficient NK cell-mediated killing while preserving inflammatory cytokine responses.

Authors:  Kiera L Clayton; Geetha Mylvaganam; Alonso Villasmil-Ocando; Heather Stuart; Marcela V Maus; Mohammad Rashidian; Hidde L Ploegh; Bruce D Walker
Journal:  Cell Host Microbe       Date:  2021-02-10       Impact factor: 21.023

6.  Antiretroviral therapy for HIV and intrahepatic hepatitis C virus replication.

Authors:  Jeffrey R Quinn; Ashish Goyal; Ruy M Ribeiro; Guido Massaccesi; Justin R Bailey; David L Thomas; Ashwin Balagopal
Journal:  AIDS       Date:  2022-03-01       Impact factor: 4.632

7.  Convergent Evolution of HLA-C Downmodulation in HIV-1 and HIV-2.

Authors:  Kristina Hopfensperger; Jonathan Richard; Christina M Stürzel; Frederic Bibollet-Ruche; Richard Apps; Marie Leoz; Jean-Christophe Plantier; Beatrice H Hahn; Andrés Finzi; Frank Kirchhoff; Daniel Sauter
Journal:  mBio       Date:  2020-07-14       Impact factor: 7.867

Review 8.  Implications of NKG2A in immunity and immune-mediated diseases.

Authors:  Xiaotong Wang; Huabao Xiong; Zhaochen Ning
Journal:  Front Immunol       Date:  2022-08-10       Impact factor: 8.786

Review 9.  TRIGGERED: could refocused cell signaling be key to natural killer cell-based HIV immunotherapeutics?

Authors:  Sho Sugawara; Cordelia Manickam; R Keith Reeves
Journal:  AIDS       Date:  2021-02-02       Impact factor: 4.632

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.